R.S. Kahn

5.3k total citations · 1 hit paper
45 papers, 4.0k citations indexed

About

R.S. Kahn is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, R.S. Kahn has authored 45 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 15 papers in Cognitive Neuroscience and 9 papers in Clinical Psychology. Recurrent topics in R.S. Kahn's work include Schizophrenia research and treatment (17 papers), Functional Brain Connectivity Studies (8 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). R.S. Kahn is often cited by papers focused on Schizophrenia research and treatment (17 papers), Functional Brain Connectivity Studies (8 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). R.S. Kahn collaborates with scholars based in Netherlands, United States and Germany. R.S. Kahn's co-authors include Michael Davidson, Gilbert Ko, A. Aleman, Nick F. Ramsey, Stephen L. Brown, H. M. van Praag, A Bleich, Iris E. Sommer, Marieke Pijnenborg and J. Martijn Jansma and has published in prestigious journals such as Journal of Neuroscience, NeuroImage and American Journal of Psychiatry.

In The Last Decade

R.S. Kahn

44 papers receiving 3.8k citations

Hit Papers

Dopamine in schizophrenia: a review and reconceptualization 1991 2026 2002 2014 1991 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.S. Kahn Netherlands 25 1.8k 1.4k 1.3k 674 601 45 4.0k
Lyn S. Pilowsky United Kingdom 38 2.0k 1.1× 1.2k 0.9× 1.5k 1.2× 646 1.0× 654 1.1× 125 4.1k
Tomiki Sumiyoshi Japan 36 2.3k 1.3× 1.6k 1.2× 1.6k 1.2× 934 1.4× 559 0.9× 217 5.0k
Mathias Zink Germany 33 1.8k 1.0× 991 0.7× 831 0.6× 506 0.8× 840 1.4× 133 3.9k
D. Pickar United States 33 1.9k 1.1× 915 0.7× 1.6k 1.3× 686 1.0× 688 1.1× 89 4.5k
Ragy R. Girgis United States 38 1.7k 0.9× 1.3k 0.9× 1.2k 0.9× 819 1.2× 533 0.9× 107 4.1k
Tomás Palomo Spain 39 1.7k 1.0× 1.2k 0.9× 1.5k 1.2× 510 0.8× 614 1.0× 157 4.5k
William S. Stone United States 40 2.2k 1.2× 2.1k 1.6× 963 0.7× 592 0.9× 811 1.3× 183 5.1k
Stephen Kanes United States 36 1.3k 0.7× 1.2k 0.9× 1.1k 0.8× 849 1.3× 655 1.1× 85 4.6k
Craig N. Karson United States 37 1.2k 0.7× 1.3k 1.0× 945 0.7× 638 0.9× 500 0.8× 83 3.9k
Gunvant K. Thaker United States 46 2.7k 1.5× 2.9k 2.1× 1.2k 0.9× 1.1k 1.7× 676 1.1× 143 6.2k

Countries citing papers authored by R.S. Kahn

Since Specialization
Citations

This map shows the geographic impact of R.S. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.S. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.S. Kahn more than expected).

Fields of papers citing papers by R.S. Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.S. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.S. Kahn. The network helps show where R.S. Kahn may publish in the future.

Co-authorship network of co-authors of R.S. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of R.S. Kahn. A scholar is included among the top collaborators of R.S. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.S. Kahn. R.S. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witte, Lot D. de, Claude van der Ley, Richard Bruggeman, et al.. (2019). Vitamin D concentration and psychotic disorder: associations with disease status, clinical variables and urbanicity. Psychological Medicine. 50(10). 1680–1686. 10 indexed citations
2.
Liemburg, Edith J., Jojanneke Bruins, Nico van Beveren, et al.. (2016). Cannabis and a lower BMI in psychosis: What is the role of AKT1?. Schizophrenia Research. 176(2-3). 95–99. 10 indexed citations
3.
Somers, Metten, Roel A. Ophoff, Maartje F. Aukes, et al.. (2015). Linkage Analysis in a Dutch Population Isolate Shows No Major Gene for Left-Handedness or Atypical Language Lateralization. Journal of Neuroscience. 35(23). 8730–8736. 42 indexed citations
4.
Dazzan, Paola, Celso Arango, Silvana Galderisi, et al.. (2015). Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research. Schizophrenia Bulletin. 41(3). 574–583. 68 indexed citations
5.
Boks, Marco P., et al.. (2008). The genetics of symptom dimensions of schizophrenia: Review and meta-analysis. Schizophrenia Research. 102(1-3). 197–205. 46 indexed citations
6.
Sommer, Iris E., Christina W. Slotema, Antoin D. de Weijer, & R.S. Kahn. (2008). fMRI-guided TMS treatment for medication resistant hallucinations. Schizophrenia Research. 98. 26–27. 1 indexed citations
7.
Sommer, Iris E., Peggy T. Cohen‐Kettenis, Lenny Ramsey, et al.. (2007). Effects of cross-sex hormones on cerebral activation during language and mental rotation: An fMRI study in transsexuals. European Neuropsychopharmacology. 18(3). 215–221. 45 indexed citations
8.
Kahn, R.S., et al.. (2007). Impaired recognition and expression of emotional prosody in schizophrenia: Review and meta-analysis. Schizophrenia Research. 96(1-3). 135–145. 187 indexed citations
9.
Vink, Matthijs, Nick F. Ramsey, Mathijs Raemaekers, & R.S. Kahn. (2005). Negative priming in schizophrenia revisited. Schizophrenia Research. 79(2-3). 211–216. 15 indexed citations
10.
Heijden, F.M.M.A. van der, S. Tuinier, R.S. Kahn, & W.M.A. Verhoeven. (2004). Nonschizophrenic Psychotic Disorders: The Case of Cycloid Psychoses. Psychopathology. 37(4). 161–167. 14 indexed citations
11.
Aleman, A., et al.. (2003). Emotional processing in a non-clinical psychosis-prone sample. Schizophrenia Research. 68(2-3). 271–281. 148 indexed citations
12.
13.
Oel, Clarine van, et al.. (2002). School Performance as a Premorbid Marker for Schizophrenia: A Twin Study. Schizophrenia Bulletin. 28(3). 401–414. 55 indexed citations
14.
Schnack, Hugo G., Hilleke E. Hulshoff Pol, William F.C. Baaré, Max A. Viergever, & R.S. Kahn. (2001). Automatic Segmentation of the Ventricular System from MR Images of the Human Brain. NeuroImage. 14(1). 95–104. 100 indexed citations
15.
Jansma, J. Martijn, Nick F. Ramsey, Richard Coppola, & R.S. Kahn. (2000). Specific versus Nonspecific Brain Activity in a Parametric N-Back Task. NeuroImage. 12(6). 688–697. 178 indexed citations
16.
Wijkstra, Jaap, Willem A. Nolen, Ale Algra, Irene M. van Vliet, & R.S. Kahn. (2000). Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatrica Scandinavica. 102(6). 454–460. 26 indexed citations
17.
Berckel, Bart N.M. van, Bob Oranje, Jan M. van Ree, M.N. Verbaten, & R.S. Kahn. (1998). The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology. 137(3). 271–281. 122 indexed citations
18.
Handelsman, Leonard, Karen Holloway, R.S. Kahn, et al.. (1996). Hostility Is Associated with a Low Prolactin Response to Meta‐chlorophenylpiperazine in Abstinent Alcoholics. Alcoholism Clinical and Experimental Research. 20(5). 824–829. 19 indexed citations
19.
Kahn, R.S.. (1993). Effect of Neuroleptic Medication on Cerebrospinal Fluid Monoamine Metabolite Concentrations in Schizophrenia. Archives of General Psychiatry. 50(8). 599–599. 48 indexed citations
20.
Bleich, A, Stephen L. Brown, R.S. Kahn, & H. M. van Praag. (1988). The Role of Serotonin in Schizophrenia. Schizophrenia Bulletin. 14(2). 297–315. 290 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026